3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
27
Carcinoma, Hepatocellular
26
Small Cell Lung Carcinoma
17
Lung Neoplasms
15
Neoplasms
13
Breast Neoplasms
8
Colorectal Neoplasms
7
Carcinoma, Renal Cell
7
Squamous Cell Carcinoma of Head and Neck
6
Melanoma
6
Uterine Cervical Neoplasms
5
Urinary Bladder Neoplasms
5
Triple Negative Breast Neoplasms
5
Neoplasm Metastasis
5
Carcinoma, Transitional Cell
5
Prostatic Neoplasms
4
Glioblastoma
4
Stomach Neoplasms
3
Solid Tumors
3
Sarcoma, Alveolar Soft Part
3
Sarcoma
3
Liver Neoplasms
3
Extensive Stage Lung Small Cell Carcinoma
3
Carcinoma
3
Treatment-Refractory Solid Tumors
2
Small Cell Lung Cancer Extensive Stage
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Osteosarcoma
2
Nasopharyngeal Carcinoma
2
Interventions
Imatinib Mesylate
6
Sunitinib
4
ripretinib
2
regorafenib
2
Specimen Handling
2
Paclitaxel
2
Magnetic Resonance Spectroscopy
2
IDRX-42
2
trastuzumab deruxtecan
1
pemigatinib
1
olverembatinib
1
envafolimab
1
atezolizumab
1
apatinib
1
Temozolomide
1
Surgical Instruments
1
Sorafenib
1
Rogaratinib
1
Nivolumab
1
Midazolam
1
Laparoscopy
1
Ipilimumab
1
Cyclophosphamide
1
CTLA-4 Antigen
1
Blood Specimen Collection
1
Biopsy
1
4-Aminopyridine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Gastrointestinal Stromal Tumors
×
atezolizumab
×
90 days
×
Clear all
NCT05152472
2026-04-24
ATEZOGIST
Centre Leon Berard
Phase 2
Recruiting
110 enrolled